array:5 [
  "content-type" => array:1 [
    0 => "text/html; charset=UTF-8"
  ]
  "cache-control" => array:1 [
    0 => "no-cache, private"
  ]
  "date" => array:1 [
    0 => "Sun, 23 Mar 2025 05:53:12 GMT"
  ]
  "set-cookie" => array:2 [
    0 => "XSRF-TOKEN=eyJpdiI6IlZKdncrUjR3UmxsT1JRUUF6THFybHc9PSIsInZhbHVlIjoibS83LzlNMmVYWkd3SDZ1YVV3NWlXMkNKNGY2cjR5T01KQldDeFNFa2wzUUV5VDNYc0p0ZjdYa0JNcXBmSnlhRGhXNjlpcnBoRnkwZk4wZC8ydDJUcjJoYkhYelA5WHhWSFhBdjdQNS9hUnZUN3ArdTdUeVZKWDN1UjQyVCsvR2IiLCJtYWMiOiI1NTJlZDQ5ZTViY2EyMzM1ZDIyMzM5YmZjNjNkODlhZmZkMTViNDM4MmExNmZkNmFmM2U2NDdkODg4OGE3YzJlIiwidGFnIjoiIn0%3D; expires=Mon, 23 Mar 2026 05:53:12 GMT; Max-Age=31536000; path=/; secure; samesite=lax"
    1 => "republica_session=eyJpdiI6IitLZGw1dU9QUkhYcTlGSkZmbW8yM1E9PSIsInZhbHVlIjoiMDVXQm1sOU95Q1BZNkJ0dVgvVWJ5cStBRmlNU0g0OWlYWnNYR1k2NFM5S0VEUjNVZVlpM2hRU2xLb0pISFU4aE84WjRLOTFseXJWQ1hhK2krekZCQndYNUpONDZ3bE1tT1dkNGp3dEgrL1pvazZXdEl4aWlkR1ZpTVJtUURCM3giLCJtYWMiOiIzYjBkYTVlN2QyNTFlMTRhZDY0MzcwN2QxYTFjN2QxZjQ3NGMwNDcwOTg0MzI5NGY3OWQ2N2I5M2Y1ZTU4ZDg5IiwidGFnIjoiIn0%3D; expires=Mon, 23 Mar 2026 05:53:12 GMT; Max-Age=31536000; path=/; secure; httponly; samesite=lax"
  ]
  "Set-Cookie" => array:2 [
    0 => "XSRF-TOKEN=eyJpdiI6IlZKdncrUjR3UmxsT1JRUUF6THFybHc9PSIsInZhbHVlIjoibS83LzlNMmVYWkd3SDZ1YVV3NWlXMkNKNGY2cjR5T01KQldDeFNFa2wzUUV5VDNYc0p0ZjdYa0JNcXBmSnlhRGhXNjlpcnBoRnkwZk4wZC8ydDJUcjJoYkhYelA5WHhWSFhBdjdQNS9hUnZUN3ArdTdUeVZKWDN1UjQyVCsvR2IiLCJtYWMiOiI1NTJlZDQ5ZTViY2EyMzM1ZDIyMzM5YmZjNjNkODlhZmZkMTViNDM4MmExNmZkNmFmM2U2NDdkODg4OGE3YzJlIiwidGFnIjoiIn0%3D; expires=Mon, 23-Mar-2026 05:53:12 GMT; path=/; secure"
    1 => "republica_session=eyJpdiI6IitLZGw1dU9QUkhYcTlGSkZmbW8yM1E9PSIsInZhbHVlIjoiMDVXQm1sOU95Q1BZNkJ0dVgvVWJ5cStBRmlNU0g0OWlYWnNYR1k2NFM5S0VEUjNVZVlpM2hRU2xLb0pISFU4aE84WjRLOTFseXJWQ1hhK2krekZCQndYNUpONDZ3bE1tT1dkNGp3dEgrL1pvazZXdEl4aWlkR1ZpTVJtUURCM3giLCJtYWMiOiIzYjBkYTVlN2QyNTFlMTRhZDY0MzcwN2QxYTFjN2QxZjQ3NGMwNDcwOTg0MzI5NGY3OWQ2N2I5M2Y1ZTU4ZDg5IiwidGFnIjoiIn0%3D; expires=Mon, 23-Mar-2026 05:53:12 GMT; path=/; secure; httponly"
  ]
]
China gives its first COVID-19 vaccine approval to Sinopharm

China gives its first COVID-19 vaccine approval to Sinopharm

Create an account, or log in
